The potential role of PKC beta in diabetic retinopathy and macular edema (Q31123344)

29 June 2017

1 reference

title

The potential role of PKC beta in diabetic retinopathy and macular edema (English)

1 reference

29 June 2017

1 reference

Lloyd Paul Aiello

1

1 reference

29 June 2017

1 December 2002

1 reference

29 June 2017

Survey of Ophthalmology

1 reference

29 June 2017

47 Suppl 2

1 reference

29 June 2017

S263-9

1 reference

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

1 reference

7 January 2021

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Retinal vascular patterns. IV. Diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Macular edema. A complication of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

How effective are treatments for diabetic retinopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Treatment of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Oxidative stress and diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Therapeutic potential of PKC inhibitors in painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Protein kinase C activation and the development of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Immunodeficiency in protein kinase cbeta-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Protein kinase C and myocardial biology and function

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

The evolution of argon laser photocoagulation scars in patients with the ocular histoplasmosis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Identification of PKC-isoform-specific biological actions using pharmacological approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Protein kinase C and the development of diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

The role of protein kinase C in the development of the complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2802%2900391-0

7 January 2021

10.1016/S0039-6257(02)00391-0

Identifiers

DOI

1 reference

29 June 2017

1 reference

PubMed ID

12507628